How long does one box of acotinib/acalatinib take?

Acalabrutinib/Acalabrutinib is a kinase inhibitor indicated for the treatment of adult patients with: mantle cell lymphoma (MCL) who have received at least one prior therapy; chronic lymphocytic leukemia (CLL); small lymphocytic lymphoma (SLL).

Acotinib is a small molecule inhibitor of BTK. Its therapeutic mechanism is to inhibit BTK enzyme activity by forming a covalent bond with the cysteine residue in the active site of BTK. BTK is a key signaling molecule in the B cell antigen receptor (BCR) and cytokine receptor pathways, playing a crucial role in the proliferation, trafficking, chemotaxis and adhesion of B cells. By inhibiting BTK enzyme activity, acotinib blocks the signaling pathways necessary for the proliferation and survival of these malignant B cells.

At recommended doses, acotinib is relatively simple to take. Patients typically require oral doses of 100 mg every 12 hours until disease progression or unacceptable toxicity. During use, patients are advised to swallow the capsules whole with water and avoid opening, breaking or chewing the capsules. Also, if a dose is missed, additional acotinib capsules should not be taken to make up for it.

As for the specifications and doses of acotinib, common specifications may include 100mg*8 tablets in 7 plates or 100mg*60 tablets. Based on these specifications, you can roughly estimate that it will take approximately one month (30 days) for a patient to take one box of acotinib. Of course, the specific taking time will also be affected by various factors such as individual patient differences, severity of illness, and doctor's recommendations.

In general, acotinib is a long-term treatment drug, and its duration and effect need to be determined based on the patient's specific situation and the doctor's recommendations. Patients should also remain vigilant at all times while taking the medicine to ensure the safety and effectiveness of the medicine.